期刊文献+

低分子肝素在普通外科手术后静脉血栓形成的预防作用 被引量:1

下载PDF
导出
摘要 目的 探讨低分子肝素对于普外科手术后静脉血栓形成的预防效果。方法 选取2012年1月~2013年6月叶县人民医院普外科收治的手术患者90例,随机均分为2组(n=45)。观察组术后低分子肝素治疗,对照组不采取此治疗手段,观察2组患者体征及B超检查结果的差异。结果 观察组45例患者中33例术后大出血患者在使用低分子肝素后有明显的缓解作用,所有患者在术后15d后均未出现血栓症状。明显好于对照组的治疗效果。结论 低分子肝素对于防止普通外科手术后静脉血栓的形成具有较好的预防作用。 ObjectiveTo observe the preventive action to venous thrombus of the low molecular weight heparin for the surgical operation. Methods Select 90 cases of patients who were for surgical operation in our hospital as the research object,divided them into observation group and control group.Treated the observation group with low molecular weight heparin and the conventional treatment method,but thecontrol group only with the conventional treatment method.Control the difference of signs and examination results by B ultrasound in two groups.Results There are 33 cases of postoperative bleeding with obvious relieve effect after using the low molecular weight heparin in patients of 45,all the patients showed no thrombosis symptoms after 15 days,better than the control group.Conclusion Low molecular weight heparin has a good preventive action to venous thrombus of the surgical operation.
作者 张进法
出处 《当代医学》 2014年第24期126-127,共2页 Contemporary Medicine
关键词 低分子肝素 普通外科手术 静脉血栓 预防作用 Low molecular weight heparin Surgical operation Venous thrombus Preventive action
  • 相关文献

参考文献3

二级参考文献27

  • 1李军,朱天岳,马忠泰,柴卫兵,卢宏章,刘震宁.低分子肝素预防髋关节置换术后深静脉血栓的安全性[J].中国矫形外科杂志,2004,12(16):1223-1225. 被引量:43
  • 2李晓祥,李耐三.低分子量肝素的抗血栓作用[J].药学进展,1994,18(1):6-10. 被引量:152
  • 3Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism[J].Cbest 2001,119(Suppl):S132-S175.
  • 4Horie H,Endo N,Sata N,et al.Postoperative venous thrombosis in genera surgery patients and perioperative prophylaxis[J].Nippon Geka Gakkai Zasshi.2005,106(3):232-236.
  • 5Anon.Prevention of fatal postoperative pulmonary embolism by low doses of heparin.An international multicentre trial[J].Lancet 1975,ii:45-51.
  • 6Levine MN,Raskob G,Landefeld S,Kearon C.Hemorrhagic complications of anticoagulant treatment[J].Cbest 2001,119:(Suppl):S 108-S121.
  • 7Lee AY,Levine MN.Management of venous thrombembolism in cancer patients[J].Oncology,2000,14(3):409.
  • 8Weitz JI.Low-molecular-weight heparins[J].N Engl J Med 1997,337:688-698.
  • 9Zacharski LR,Prandoni P,Monreal M.Warfarin versus low-molecular-weight heparin therapy in cancer patients[J].Oncologist.2005,10(1):72-79.
  • 10Sasahara AA,Koppenhagen K,Haring R,et al.Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis[J].Br J Surg 1986,73:697-700.

共引文献160

同被引文献24

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部